News Agency
Men's Weekly

BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc.

  • Written by PR Newswire
BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc.

VANCOUVER, BC, Feb. 13, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced that it has executed the definitive  Asset Purchase Agreement dated February 11th, 2024 to acquire the entire portfolio of discovery, preclinical and clinical development stage assets in oncology,...

Read more: BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical...

Furniture Movers Sydney: Complete Guide to Safe and Efficient Moving

Moving furniture in a busy city like Sydney can be a complex task. High rise apartments, narrow streets, traffic congestion, and strict building regulations all add extra challenges to the moving process. Whether you are relocating your home or office... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion